Page 93 - EJMO-9-2

Eurasian Journal of Medicine and
Oncology
Cancer pathway ranking through odds ratios

Availability of data molecular to clinical aspects. Int J Mol Sci. 2022;23(17):10132.

Data supporting the findings of this study are available doi: 10.3390/ijms231710132
from the corresponding author on reasonable request. 13. Fadhal E. A comprehensive analysis of the PI3K/AKT
pathway: Unveiling key proteins and therapeutic targets for
References cancer treatment. Cancer Inform. 2023;22.
1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next doi: 10.1177/11769351231194273
generation. Cell. 2011;144(5):646-674.
14. Hnisz D, Weintraub AS, Day DS, et al. Activation of proto-
doi: 10.1016/j.cell.2011.02.013 oncogenes by disruption of chromosome neighborhoods.
2. Franceschini A, Szklarczyk D, Frankild S, et al. STRING Science. 2016;351(6280):1454-1458.
v9. 1: Protein-protein interaction networks, with doi: 10.1126/science.aad9024
increased coverage and integration. Nucleic Acids Res.
2012;41(D1):D808-D815. 15. Zhang L, Guo Y, Li B, et al. Identification of biomarkers
for hepatocellular carcinoma using network-based
doi: 10.1093/nar/gks1094 bioinformatics methods. Eur J Med Res. 2013;18:35.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. doi: 10.1186/2047-783X-18-35
2000;100(1):57-70.
16. Gill R, Datta S, Datta S. A statistical framework for
doi: 10.1016/s0092-8674(00)81683-9 differential network analysis from microarray data. BMC
4. Vogelstein B, Kinzler KW. Cancer genes and the pathways Bioinformatics. 2010;11:95.
they control. Nat Med. 2004;10(8):789-799. doi: 10.1186/1471-2105-11-95
doi: 10.1038/nm1087 17. Fadhal E, Gamieldien J, Mwambene EC. Protein interaction
5. Barabási AL, Gulbahce N, Loscalzo J. Network medicine: networks as metric spaces: A novel perspective on
A network-based approach to human disease. Nat Rev distribution of hubs. BMC Syst Biol. 2014;8:6.
Genet. 2011;12(1):56-68. doi: 10.1186/1752-0509-8-6
doi: 10.1038/nrg2918 18. Fadhal E, Mwambene EC, Gamieldien J. Modelling human
6. Futreal PA, Coin L, Marshall M, et al. A census of human protein interaction networks as metric spaces has potential
cancer genes. Nat Rev Cancer. 2004;4(3):177-183. in disease research and drug target discovery. BMC Syst Biol.
2014;8:68.
doi: 10.1038/nrc1299
doi: 10.1186/1752-0509-8-68
7. Jiang N, Dai Q, Su X, Fu J, Feng X, Peng J. Role of PI3K/AKT
pathway in cancer: The framework of malignant behavior. 19. Davis AP, Grondin CJ, Johnson RJ, et al. Comparative
Mol Biol Rep. 2020;47(6):4587-4629. toxicogenomics database (CTD): Update 2021. Nucleic Acids
Res. 2021;49(D1):D1138-D1143.
doi: 10.1007/s11033-020-05435-1
doi: 10.1093/nar/gkaa891
8. Smyth MJ, Johnstone RW. Role of TNF in lymphocyte‐
mediated cytotoxicity. Microsc Res Tech. 2000;50(3):196-208. 20. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S,
Diaz LA Jr., Kinzler KW. Cancer genome landscapes. Science.
doi: 10.1002/1097-0029(20000801)50:3<196:AID-JEMT3>3.0.CO;2-9
2013;339(6127):1546-1558.
9. Mondal D, Narwani D, Notta S, Ghaffar D, Mardhekar N, doi: 10.1126/science.1235122
Quadri SS. Oxidative stress and redox signaling in CRPC
progression: Therapeutic potential of clinically-tested Nrf2- 21. Viera AJ. Odds ratios and risk ratios: What’s the difference
activators. Cancer Drug Resist. 2021;4(1):96-124. and why does it matter? South Med J. 2008;101(7):730-734.
doi: 10.20517/cdr.2020.71 doi: 10.1097/SMJ.0b013e31817a7ee4
10. Reya T, Clevers H. Wnt signalling in stem cells and cancer. 22. Davis AP, Grondin CJ, Johnson RJ, et al. The comparative
Nature. 2005;434(7035):843-850. toxicogenomics database: Update 2019. Nucleic Acids Res.
2019;47(D1):D948-D954.
doi: 10.1038/nature03319
doi: 10.1093/nar/gky868
11. Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Targeting
mTOR for cancer therapy. J Hematol Oncol. 2019;12:71. 23. Aggarwal BB. Signalling pathways of the TNF superfamily:
A double-edged sword. Nature Rev Immunol. 2003;3(9):745-756.
doi: 10.1186/s13045-019-0754-1
doi: 10.1038/nri1184
12. Stanciu S, Ionita-Radu F, Stefani C, et al. Targeting PI3K/
AKT/mTOR signaling pathway in pancreatic cancer: From 24. Grivennikov SI, Greten FR, Karin M. Immunity,

Volume 9 Issue 2 (2025) 85 doi: 10.36922/ejmo.8082